JP2017513927A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513927A5 JP2017513927A5 JP2016575314A JP2016575314A JP2017513927A5 JP 2017513927 A5 JP2017513927 A5 JP 2017513927A5 JP 2016575314 A JP2016575314 A JP 2016575314A JP 2016575314 A JP2016575314 A JP 2016575314A JP 2017513927 A5 JP2017513927 A5 JP 2017513927A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- item
- self
- target area
- assembling peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461950529P | 2014-03-10 | 2014-03-10 | |
| US61/950,529 | 2014-03-10 | ||
| US201461953221P | 2014-03-14 | 2014-03-14 | |
| US61/953,221 | 2014-03-14 | ||
| PCT/US2015/019738 WO2015138473A1 (en) | 2014-03-10 | 2015-03-10 | Autoassembling peptides for the treatment of pulmonary leakage |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019194312A Division JP2020011125A (ja) | 2014-03-10 | 2019-10-25 | 肺の漏出を治療するための自発組織化ペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017513927A JP2017513927A (ja) | 2017-06-01 |
| JP2017513927A5 true JP2017513927A5 (enExample) | 2018-07-26 |
Family
ID=52737413
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016575314A Pending JP2017513927A (ja) | 2014-03-10 | 2015-03-10 | 肺の漏出を治療するための自発組織化ペプチド |
| JP2019194312A Pending JP2020011125A (ja) | 2014-03-10 | 2019-10-25 | 肺の漏出を治療するための自発組織化ペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019194312A Pending JP2020011125A (ja) | 2014-03-10 | 2019-10-25 | 肺の漏出を治療するための自発組織化ペプチド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20170173105A1 (enExample) |
| EP (1) | EP3116522B1 (enExample) |
| JP (2) | JP2017513927A (enExample) |
| ES (1) | ES2729214T3 (enExample) |
| WO (1) | WO2015138473A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435211A (zh) | 2008-10-06 | 2016-03-30 | 三维肽胶株式会社 | 组织闭塞剂 |
| EP2869903B1 (en) | 2012-07-06 | 2018-11-28 | 3-D Matrix Ltd. | Fill-finish process for peptide solutions |
| US20160287744A1 (en) | 2012-11-14 | 2016-10-06 | 3-D Matrix Ltd. | Vascular embolic system |
| ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
| DK3116896T3 (en) | 2014-03-10 | 2019-03-18 | 3 D Matrix Ltd | SELF-PREPARING PEPTIME COMPOSITIONS |
| ES3037364T3 (en) | 2014-03-10 | 2025-10-01 | 3 D Matrix Ltd | Sterilization and filtration of peptide compositions |
| WO2017120092A1 (en) * | 2016-01-06 | 2017-07-13 | 3-D Matrix, Ltd. | Combination compositions |
| CN117085140A (zh) | 2017-12-15 | 2023-11-21 | 立美基股份有限公司 | 表面活性剂肽纳米结构及在药物递送中的用途 |
| CN112368295B (zh) | 2018-07-03 | 2025-03-21 | 立美基股份有限公司 | 离子性自组装肽 |
| CN115397454A (zh) | 2020-03-31 | 2022-11-25 | 立美基股份有限公司 | 通过辐照对自组装肽进行灭菌 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2364939A1 (en) * | 1999-12-22 | 2001-06-28 | Surgical Sealants, Inc. | Methods and compositions for sealing tissue leaks |
| US20040242469A1 (en) * | 2002-05-13 | 2004-12-02 | Lee Richard T. | Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof |
| EP1796746B1 (en) * | 2004-10-07 | 2011-05-04 | E.I. Du Pont De Nemours And Company | Polysaccharide-based polymer tissue adhesive for medical use |
| HUE037994T2 (hu) * | 2006-04-25 | 2018-09-28 | Massachusetts Inst Technology | Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására |
| CN105435211A (zh) * | 2008-10-06 | 2016-03-30 | 三维肽胶株式会社 | 组织闭塞剂 |
| JP6034868B2 (ja) * | 2011-09-02 | 2016-11-30 | 株式会社スリー・ディー・マトリックス | 胸部の空気漏れ閉塞のための両親媒性ペプチド |
-
2015
- 2015-03-10 JP JP2016575314A patent/JP2017513927A/ja active Pending
- 2015-03-10 ES ES15712231T patent/ES2729214T3/es active Active
- 2015-03-10 EP EP15712231.8A patent/EP3116522B1/en active Active
- 2015-03-10 WO PCT/US2015/019738 patent/WO2015138473A1/en not_active Ceased
- 2015-03-10 US US15/124,638 patent/US20170173105A1/en not_active Abandoned
-
2019
- 2019-10-25 JP JP2019194312A patent/JP2020011125A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017513928A5 (enExample) | ||
| JP2017510400A5 (enExample) | ||
| US10952961B2 (en) | Implants and constructs including hollow fibers | |
| JP2016513523A5 (enExample) | ||
| US20220160939A1 (en) | Self-assembling peptides as bronchial obstruction agents | |
| US6610206B1 (en) | Buffered compositions for dialysis | |
| US20170072008A1 (en) | Autoassembling peptides for the treatment of pulmonary bulla | |
| CA2703234C (en) | An inhalable dry powder formulation comprising glp-1 for use by pulmonary inhalation | |
| JP2016515113A5 (enExample) | ||
| EP3116522B1 (en) | Autoassembling peptides for the treatment of pulmonary leakage | |
| JP2017503852A5 (enExample) | ||
| AR045956A1 (es) | Multiparticulas de pantoprazol y formulacion que las contiene | |
| ES2985515T3 (es) | Nuevo régimen de dosificación para polipéptido intestinal vasoactivo inhalado | |
| Cordery et al. | Simultaneous transdermal delivery of buprenorphine hydrochloride and naltrexone hydrochloride by iontophoresis | |
| RU2017124487A (ru) | НОВЫЙ ПЕПТИД-ИНГИБИТОР PI3Kγ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ОРГАНОВ ДЫХАНИЯ | |
| EP4578461A3 (en) | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa | |
| ES2438971T3 (es) | Composiciones tamponadas para diálisis | |
| ES3035910T3 (en) | Medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysis | |
| JP2019518569A5 (enExample) | ||
| JP2021185141A (ja) | サルコイドーシスを処置するための１，３−プロパンジスルホン酸またはその薬学的に許容される塩の使用 | |
| HRP20161634T1 (hr) | Novi pripravak alfentanila za liječenje akutne boli | |
| JP2019508416A (ja) | 術後認知機能障害の処置のための方法及び医薬組成物 | |
| Djani et al. | Congestive heart failure caused by transvenous pacemaker lead prolapse and associated right ventricular outflow tract obstruction in a dog | |
| KR102244530B1 (ko) | 뇌 및 전신의 재관류 손상을 예방하거나 감소시키기 위한 보호 용액 | |
| CN111971046A (zh) | 用于防护或减轻辐射损伤以及用于预防或治疗肺纤维化的用途 |